First Circuit asks Sanofi to prove patent claims were in good faith
Direct purchasers stated a claim for monopolisation against Sanofi-Aventis, the US Court of Appeals for the First Circuit has held, and the drugmaker must prove its defence was in good faith.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10